We are live on ! Find out more
WA

WestEnd Advisors Portfolio holdings

AUM $4.49B
1-Year Est. Return 19.44%
This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+19.44%
3 Year Est. Return
+59.91%
5 Year Est. Return
+54.26%
10 Year Est. Return
+227.54%
AUM
$3.22B
AUM Growth
+$160M
Cap. Flow
-$3.18B
Cap. Flow %
-98.72%
Top 10 Hldgs %
69.71%
Holding
334
New
–
Increased
–
Reduced
–
Closed
311

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$406M
2
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$396M
3
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$291M
4
VPL icon
Vanguard FTSE Pacific ETF
VPL
+$247M
5
XLC icon
State Street Communication Services Select Sector SPDR ETF
XLC
+$174M

Sector Composition

Rank Sector Weight
1 Miscellaneous 78.75%
2 Healthcare 5.68%
3 Technology 4.53%
4 Communication Services 4.14%
5 Consumer Staples 2.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRE icon
101
Sempra
SRE
$55B
– –
-14
Closed -$1.07K
CI icon
102
Cigna
CI
$74.7B
– –
-4
Closed -$1.17K
ISRG icon
103
Intuitive Surgical
ISRG
$130B
– –
-4
Closed -$985
ZTS icon
104
Zoetis
ZTS
$31.3B
– –
-5
Closed -$819
BDX icon
105
Becton Dickinson
BDX
$50.3B
– –
-3
Closed -$734
NKE icon
106
Nike
NKE
$57B
– –
-8
Closed -$983
AMD icon
107
Advanced Micro Devices
AMD
$780B
– –
-12
Closed -$977
HUM icon
108
Humana
HUM
$48.2B
– –
-2
Closed -$989
BSX icon
109
Boston Scientific
BSX
$69.3B
– –
-18
Closed -$848
VRTX icon
110
Vertex Pharmaceuticals
VRTX
$138B
– –
-3
Closed -$900
ORCL icon
111
Oracle
ORCL
$457B
– –
-11
Closed -$965
EXC icon
112
Exelon
EXC
$45B
– –
-21
Closed -$875
INTC icon
113
Intel
INTC
$506B
– –
-30
Closed -$850
CL icon
114
Colgate-Palmolive
CL
$70.8B
– –
-10
Closed -$744
INTU icon
115
Intuit
INTU
$91B
– –
-2
Closed -$821
SBUX icon
116
Starbucks
SBUX
$119B
– –
-7
Closed -$729
TGT icon
117
Target
TGT
$74.7B
– –
-3
Closed -$493
REGN icon
118
Regeneron Pharmaceuticals
REGN
$85.2B
– –
-1
Closed -$754
XEL icon
119
Xcel Energy
XEL
$47.3B
– –
-12
Closed -$810
LOW icon
120
Lowe's Companies
LOW
$115B
– –
-4
Closed -$813
SHYG icon
121
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.75B
– –
-19
Closed -$787
HCA icon
122
HCA Healthcare
HCA
$87.7B
– –
-2
Closed -$508
IBM icon
123
IBM
IBM
$221B
– –
-6
Closed -$803
ED icon
124
Consolidated Edison
ED
$39.7B
– –
-8
Closed -$749
EL icon
125
Estee Lauder
EL
$37.6B
– –
-3
Closed -$762
3 4
5
6 7

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $4.49B AUM 6.4% 1-Year Est. Return
DACG
Donor Advised Charitable Giving San Francisco, California $4.49B AUM 26.39% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
U
Uber San Francisco, California $4.51B AUM 1.92% 1-Year Est. Return
ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $4.46B AUM
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.52B AUM 31.84% 1-Year Est. Return

WestEnd Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, WestEnd Advisors held 334 positions worth $3.22B, up 5.2% from $3.06B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

WestEnd Advisors withdrew a net $3.18B in Q1 2023, closing 311 positions. Its most notable exit was State Street Health Care Select Sector SPDR ETF, an estimated $406M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 79% a quarter earlier, followed by Healthcare and Technology.

  • WestEnd Advisors fully exited State Street Health Care Select Sector SPDR ETF in Q1 2023, selling an estimated $406M.
  • WestEnd Advisors's ten largest holdings make up 70% of its $3.22B portfolio in Q1 2023.
  • WestEnd Advisors opened 0 new positions and closed 311 in Q1 2023.
  • WestEnd Advisors's portfolio value rose 5.2% quarter-over-quarter to $3.22B.

Based on WestEnd Advisors's 13F filing for Q1 2023, filed 28 Apr 2023.